Latest
Thromboprophylaxis Is Safe and Effective in Patients With High-Risk Cancer
Effectiveness of Corticosteroids in the Treatment of Chemotherapy-Induced Thrombocytopenia
Superior Efficacy With Copanlisib Plus Rituximab vs Placebo Plus Rituximab in Patients With Relapsed Marginal Zone Lymphoma
COVID-19: What Do We Know About Outcomes in Hematologic Malignancies?
Technology-Based Psychosocial Program Effective for Adolescent Leukemia Survivors
Tipifarnib May Yield Response in Chronic Myelomonocytic Leukemia or Other Myelodysplastic, Myeloproliferative Neoplasms
ONKOTEV Scoring System May Be Predictive of VTE Risk Among Outpatients With Cancer
R-NPLD Combination Treatment Safe and Effective for Patients With Diffuse Large B-Cell Lymphoma
APN Follow-Up Intervention Improves Care for Patients With Multiple Myeloma
Interleukin-6 Levels May Predict PFS in Relapsed/Refractory Hodgkin Lymphoma Treated With Nivolumab
Patients With Cancer and COVID-19 Face Increased Risk of Thromboembolic Events
Botanical-Derived Drug May Be Clinically Active in Multiple Cancer Types
Featured Content
Age, Race May Determine Whether Cancer Patients Access EHRs
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.
Racial/Ethnic Minorities Have Higher Risk of Familial-Associated Early-Onset Cancer
The study showed differences by cancer type and race/ethnicity.
How to Manage Venetoclax Resistance in CLL
Experts outline treatment options for patients with venetoclax resistance.
GRASP: Closing the Gap Between Cancer Patients and Researchers
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
- Loading...
Loading...
Loading... 
Loading...